| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |